Home / KIF18B Knockout Cell Lines

KIF18B Knockout Cell Lines

Gene: KIF18B

Official Full Name: kinesin family member 18Bprovided by HGNC

Gene Summary: Enables cytoskeletal motor activity and kinesin binding activity. Involved in microtubule depolymerization; mitotic cell cycle; and regulation of cell division. Located in cytosol; microtubule; and nuclear body. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO23932 KIF18B Knockout cell line (HeLa) Human KIF18B 1:3~1:6 Negative Online Inquiry
KO23933 KIF18B Knockout cell line (HCT 116) Human KIF18B 1:2~1:4 Negative Online Inquiry
KO23934 KIF18B Knockout cell line (HEK293) Human KIF18B 1:3~1:6 Negative Online Inquiry
KO23935 KIF18B Knockout cell line (A549) Human KIF18B 1:3~1:4 Negative Online Inquiry

Background

KIF18B Gene Knockout Cell Lines are genetically engineered cell lines that have had the KIF18B gene inactivated, allowing for the investigation of its role in cellular processes, particularly those related to cell division and mitotic regulation. KIF18B is a kinesin motor protein involved in the transport of organelles and mRNA, as well as being crucial for proper spindle dynamics during mitosis. By providing a model system in which the KIF18B function is ablated, researchers can study the downstream effects of its loss, offering insights into potential pathways and interactions that may be involved in various biological functions and diseases, including cancer.

These knockout cell lines operate on the principle of gene editing technologies, such as CRISPR-Cas9, which facilitate precise alterations to the genome. By targeting the KIF18B gene, scientists can observe phenotypic changes and cellular responses, allowing for a deeper understanding of mitotic abnormalities and their implications in tumorigenesis. Importantly, these models enable experimental reproducibility and validation of findings in a controlled environment, aiding the development of novel therapies.

Given the increasing importance of understanding the molecular mechanisms of cancer and other proliferative diseases, KIF18B Gene Knockout Cell Lines are valuable tools in both research and clinical settings. Unlike other cell lines that may exhibit varying levels of the KIF18B protein, these knockout lines provide a clean background, eliminating confounding factors and enhancing the validity of experimental outcomes.

Researchers and clinicians looking to investigate the role of KIF18B in pathology will find these cell lines instrumental in uncovering new therapeutic targets and strategies. The ability to manipulate and assess the functional consequences of the absence of this critical gene underpins their application in high-impact studies.

Our company specializes in producing high-quality, genetically modified cell lines accompanied by comprehensive technical support and validation studies. With a commitment to advancing scientific discovery, we offer expertly crafted biological tools designed to propel research forward, ensuring you have access to the latest innovations in cellular models.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.